CHAPEL HILL, N.C.--(BUSINESS WIRE)--e-Nicotine Technology (eNT) today announced details regarding its family of products aimed at helping smokers as they transition off of combustible cigarettes. Having recently completed clinical trials in nearly 100 smokers and showing rapid (within 1-minute), dramatic (up to 83% reduction) and sustained smoking urge reduction, eNT is moving forward toward the launch of its family of state-of-the-art electronic nicotine delivery products.
“We believe that our products are poised to capture a significant market share given that they can be marketed at a substantially lower cost, can be used discreetly, and will help consumers rid themselves of a habit that has been shortening lives for decades,” said Jeff Williams, Chief Executive Officer of eNT. “Additionally, our product platform is amendable to eventual development as a more traditional nicotine replacement therapy (NRT), which are marketed for smoking cessation by pharmaceutical companies like GlaxoSmithKline, Johnson & Johnson, Novartis, and Pfizer. For our initial product, we will be launching commercially across Europe first.”
eNT’s technology enables the development of products that do not look like cigarettes or e-cigarettes and emit no secondhand vapor, which prevents family members or the public from being exposed to the thick plumes of chemicals from existing e-cigarettes, giving users a satisfying and discreet nicotine experience anytime, anywhere. eNT’s initial launch product includes a reusable electronic controller that comes standard with an interface to proprietary mobile e-health tools allowing each user to carefully track their usage and help them to transition completely off of cigarettes and nicotine if they choose.
Existing electronic cigarettes such as NJOY, blu eCigs (NYSE:LO), MarkTen (NYSE:MO), and Victory electronic cigarettes (OTCMKTS:ECIG) rely exclusively on a form factor that intentionally mimics traditional combustible cigarettes, such as those from British American Tobacco (NYSEMKT:BTI), Lorillard (NYSE:LO), Phillip Morris (NYSE:PM), and Reynolds American (NYSE:RAI). As a result, many public health and tobacco control experts have noted that e-cigs risk re-glamorizing smoking behavior: “By developing a family of electronic nicotine delivery devices that do not look like cigarettes, emit no secondhand vapor, and provide a consistent dose with each inhalation, we are pursuing an important and novel approach to helping smokers,” said Dr. Michael Hufford, Chief Medical Officer of eNT.
About e-Nicotine Technology
eNT is a healthcare company committed to reducing the harms associated with combustible tobacco products. eNT is developing the next generation of state-of-the-art electronic nicotine delivery products that quickly and dramatically reduce smoking urge while using 40-70% less nicotine than cigarettes or existing e-cigarettes. eNT’s products deliver consistent doses of nicotine and emit no secondhand vapor, giving consumers a discreet and satisfying nicotine experience anytime, anywhere.
For more information about eNT, its technology, products and other inquiries, please contact: Justin Bingham, VP Corporate Development at +1.801.502.3458 or firstname.lastname@example.org, http://www.enicotinetechnology.com.